North Texas Infectious Disease Consultants

What North Texas Infectious Disease Consultants does

North Texas Infectious Disease Consultants (NTIDC) is a private, physician-owned infectious disease medical practice headquartered in Dallas, Texas, with two clinic locations—one co-located on the Baylor University Medical Center campus at 3409 Worth Street, Suite 710, and a second at 12222 North Central Expressway, Pavilion II. Founded by Dr. Louis Sloan, the practice operates with 101–250 employees and delivers specialty care for bacterial, fungal, transplant, viral (HIV, Hepatitis B & C, HPV, herpes), sexually transmitted, and immunodeficiency-related infections. Service delivery rests on clinical consultations, an on-site infusion suite with PICC and mid-line placement, an on-site pharmacy, and a dedicated research department.

The practice generates revenue across four streams: patient medical services billed through insurance, infusion therapy (antibiotics, antifungals, antivirals, IVIG), on-site pharmacy dispensing, and clinical research participation. The research department conducts Phase I–IV trials across all major antiretroviral drug classes and is recognized as one of the most respected and sought-after clinical trial sites in north Texas, with top-enroller recognition at CROI in three HIV trials. Distribution is primarily regional (North Texas), accessed via physician referrals, hospital consultations at Baylor University Medical Center, direct patient appointments, and clinical trial enrollment; patients reach the practice through an enterprise-style field motion supported by an online patient portal, appointment booking, and online payments.

Operationally, NTIDC is anchored by an academic and institutional ecosystem: Dr. Mezgebe Berhe serves as Program Director of the Infectious Disease Fellowship Program at Baylor University Medical Center, chairs its antimicrobial, neutropenic fever, and quality committees, and holds a Clinical Associate Professorship at Texas A&M. The provider roster includes three ID physicians (Berhe, Haley, Bettacchi), one DO (Nicoletti), four physician assistants/nurse practitioners (Huggins, Kitchens, Prieto, Jablonski, Shaw), and a research staff supporting trials. The practice collaborates with the Baylor Institute of Immunology Research on HIV vaccine studies and operates a Hospital Avoidance Program that offers referring physicians an outpatient alternative to inpatient admission or ED visits.

Name

North Texas Infectious Disease Consultants

Legal name

North Texas Infectious Diseases Consultants

Website

https://infectiousdiseases.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

101–250 employees

Short description

North Texas Infectious Disease Consultants is a private, physician-owned infectious disease practice in Dallas, TX, treating HIV/AIDS, hepatitis, bacterial, fungal, transplant, and STI infections through two clinic locations, an on-site infusion suite, on-site pharmacy, and an active Phase I–IV clinical trial program affiliated with Baylor University Medical Center.

Ownership category

akta.pro rank

Product category

Infectious Disease Healthcare Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111), Ambulatory Health Care Services (621), Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

General Infectious Disease (HLAKAGAA)

Keywords

• Infectious disease care
• Antiviral therapy services
• Infusion therapy services
• HIV medical care
• Clinical trial research

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D

Revenue model

1. Patient Medical Services: Revenue from treating infectious diseases including HIV, Hepatitis B & C, bacterial, fungal, transplant infections, STIs, and immunodeficiencies
2. Infusion Therapy: Drug therapies administered via infusion including antibiotics, antifungals, antivirals, specialty medications including IVIG
3. Clinical Research: Participation in clinical trials for antiretroviral drugs including Protease Inhibitors, NNRTIs, NRTIs, Integrase Inhibitors, and Entry Inhibitors
4. Onsite Pharmacy: Pharmacy services for medications and prescription fulfillment

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

North Texas Infectious Disease Consultants is a private medical practice based in Dallas, TX that specializes in the diagnosis and treatment of infectious diseases. The practice provides antiviral therapy, infusion therapy, HIV care, and conducts clinical trials for patients with various infectious conditions.

Product overview

North Texas Infectious Diseases Consultants (NTIDC) is a medical practice offering a comprehensive suite of infectious disease treatment services centered around their core clinical offerings. The practice operates as a single integrated care model combining infectious diseases treatment, anti-viral therapy, hospital avoidance programs, and infusion therapy with integrated onsite pharmacy services. Their research department conducts Phase I-IV clinical trials primarily focused on HIV and infectious diseases, providing patients access to experimental treatments. Digital services include patient portal access, online appointment booking, and online payment systems. The practice has two locations in Dallas, Texas and maintains affiliations with Baylor University Medical Center.

Differentiator

Problem solved

Functional benefit

Products and services

• Infectious Disease Treatment Comprehensive medical evaluation, diagnosis, and treatment for patients with a wide range of infectious diseases. Targeted at adult patients in the North Texas region referred for specialty infectious disease care.
• Antiviral Therapy Medical treatment using antiviral medications prescribed and managed for patients with viral infections. Targeted at patients requiring antiviral drug regimens.
• Infusion Therapy Services Outpatient intravenous infusion therapy for patients requiring IV-administered medications, including antimicrobials and other specialty infusions. Targeted at patients whose treatment plans call for infusion-based therapy.
• HIV Care Program Specialized medical care, monitoring, and treatment for patients living with HIV, including antiretroviral therapy management. Targeted at adult patients living with HIV in the North Texas region.
• Clinical Trial Research Participation in clinical trials for new treatments and therapies related to infectious diseases, offering patients access to investigational options. Targeted at patients seeking access to emerging therapies and contributing to infectious disease research.

Quantifiable outcome

• Recognized as top enroller in 3 HIV clinical trials at CROI conference

Named customers4 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Baylor Institute of Immunology Research (BIIR)coreStrategic or Co-development PartnerCollaboration with Baylor Institute of Immunology Research to study therapeutic vaccines for HIV treatment. The Research Department enables participation in intense pharmacokinetic studies and works with pharmaceutical companies on development of new antiretroviral therapies and vaccines.
• Baylor University Medical CentercoreStrategic or Co-development PartnerPrimary affiliated hospital where physicians practice and conduct research. Houses the Infectious Disease Fellowship Program. All trials conducted at Research Department located on Baylor campus.
• Texas A&M UniversityminorStrategic or Co-development PartnerDr. Berhe serves as Clinical Associate Professor of Medicine with Texas A&M University, involved in medical education and fellowship program development.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Others

• Quest Diagnostics: National clinical laboratory and diagnostic services company. NTIDC's research department performs PK studies and laboratory testing; Quest is the relevant ecosystem comparator for clinical lab infrastructure behind an ID research site.
• Labcorp: Major clinical laboratory services provider with extensive infectious disease and HIV testing capabilities. Acts as the broader lab-services comparator and potential central lab partner for NTIDC-sponsored clinical trials.
• ICON plc: Global clinical research organization (CRO) running infectious disease and HIV trials. As an established trial-sponsor counterpart, ICON is the relevant adjacent 'customer' peer for NTIDC's site-management business.

Broad incumbents

• AIDS Healthcare Foundation (AHF): Largest global HIV/AIDS service organization operating outpatient HIV clinics, pharmacies, and clinical research programs across the US; a relevant broader incumbent competing for HIV patients and serving as a structural ceiling for independent HIV-focused practices.
• ID Care (New Jersey): One of the largest independent infectious disease specialist groups in the US, operating across multiple New Jersey locations with hospital consultations, infusion services, and HIV/Hepatitis programs — a relevant scale benchmark for what a multi-site ID group can become.

Direct peers

• Triangle Infectious Diseases: Raleigh-Durham NC-based independent infectious disease specialty practice offering HIV care, hepatitis treatment, infusion therapy, and clinical research; structurally similar mid-size ID group serving a single regional market.
• Orlando Immunology Center: HIV and infectious disease specialty practice in Orlando with clinical research focus, onsite pharmacy, and longitudinal HIV care — directly comparable to NTIDC's HIV-primary, research-enabled outpatient model.
• Atlanta ID Group: Multi-physician infectious disease practice in Atlanta with HIV, hepatitis, and general ID focus plus clinical trial participation; comparable peer given similar specialty mix and outpatient delivery model in a different mid-sized US metro.
• Dallas ID Associates: Infectious disease specialist practice serving the Dallas–Fort Worth metro. Operates as a multi-physician outpatient ID group with overlapping patient population and referral sources, making it the most direct head-to-head competitor to NTIDC.

Regional players

• Houston Infectious Diseases Associates: Established multi-physician infectious disease practice in Houston, Texas with similar specialty focus on HIV, hepatitis, and general ID; comparable in clinical trial portfolio and outpatient infusion capabilities to NTIDC but operating in a separate Texas market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ntidc
• YouTubeyoutube.com/channel/UCm2OOXEbT1nVvPnw-jYePOw
• Facebookfacebook.com/NTIDCTX
• LinkedInlinkedin.com/company/ntidc
• Instagraminstagram.com/ntidc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about North Texas Infectious Disease Consultants